Amgen
The Competitive Intelligence Senior Manager, Global Biosimilars leads the CI strategy for Amgen's biosimilars pipeline, overseeing intelligence gathering, AI‑enabled analytics, and vendor management. The role translates competitor insights into actionable recommendations for senior leadership and ensures compliance with legal and ethical standards. It also mentors internal and external partners, integrates diverse data sources, and presents strategic recommendations to drive business decisions.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
54% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Competitive Intelligence Senior Manager, Global Biosimilars
Sparrow
Global Market & Competitive Intelligence Manager
C0000032578P
Executive Director, US Brand Lead – Oncology Biosimilars
lifelancer
Competitive Intelligence Analyst
eFinancial
Director of Competitive Intelligence
lifelancer
GLOBAL MEDICAL SAFETY EXPERT – BIOSIMILARS
Abbott Laboratories